NYSE American - Delayed Quote • USD Myomo, Inc. (MYO) Follow Compare 6.15 -0.03 (-0.49%) At close: January 16 at 4:00:00 PM EST 6.15 0.00 (0.00%) After hours: January 16 at 4:04:59 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock BOSTON, December 05, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has priced an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per share. Myomo expects the gross proceeds from this offering to be approximately $15.0 million, before deducting the underwriting discount Myomo, Inc. Announces Proposed Public Offering of Common Stock BOSTON, December 04, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. In connection with the offering, Myomo also expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives Myomo Inc (MYO) reports an 83% revenue increase, strategic partnerships, and international expansion amid operational challenges. Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates Myomo (MYO) delivered earnings and revenue surprises of 25% and 15.82%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? Myomo Reports Record Third Quarter Financial and Operating Results BOSTON, November 06, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and nine months ended September 30, 2024. Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage BOSTON, October 31, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces it has entered into the first contracts that will allow MyoPro to be provided to patients covered by private insurance on an in-network basis. Myomo to Report Third Quarter Financial Results on November 6, 2024 BOSTON, October 30, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter ended September 30, 2024 on November 6, 2024. Myomo Inc (MYO) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion ... Myomo Inc (MYO) reports a 77% revenue surge and outlines plans for increased manufacturing capacity and market expansion. Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit BOSTON, October 09, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will participate in a "Fireside Chat" at the 2024 Maxim Healthcare Virtual Summit. The virtual summit is being presented by Maxim Group LLC, from Octob Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly BOSTON, September 12, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the official launch of the Myomo Academy, a comprehensive learning management system for professionals in Orthotics & Prosthetics (O&P) and Rehabilitation. Myomo to Participate in Two Investor Conferences in September BOSTON, September 05, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be participating in two investor conferences during the month of September. Myomo Reports Second Quarter 2024 Financial Results BOSTON, August 06, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2024. Myomo to Report Second Quarter Financial Results on August 6, 2024 BOSTON, July 30, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter ended June 30, 2024 on August 6, 2024. The 3 Best Robotic Exoskeleton Stocks to Buy Now An exciting, under-the-radar development is unfolding. I’m referring to the development of Robotic Exoskeletons, a phenomenon that could literally be life-changing to some. This has also opened the door to the best Robotic Exoskeleton stocks. For those unaware, Robotic Exoskeletons attach to the human body to aid mechanical movement. Among other reasons, the concept was designed to provide paralyzed individuals with a more convenient life. Although in its early stages, exoskeleton development ha Myomo, Inc. (MYO): Hedge Funds Are Bullish on This Robotics Stock Now We recently compiled a list of the 8 Best Robotics Stocks Under $10. In this article, we are going to take a look at where Myomo, Inc. (NYSE:MYO) stands against the other robotic stocks under $10. The concept of lifelike machines performing human tasks is fascinating to some and unsettling to others. However, robotics is […] Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics BOSTON, July 08, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, reports preliminary revenues and operating metrics for the three months ended June 30, 2024. Sidoti Events, LLC's Virtual June Small-Cap Conference NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. ... Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024 BOSTON, June 05, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief executive officer and David Henry, chief financial officer, will present and host one-on-one meetings with investors at the Sidoti Virtual Investor conference being held on June 12-13, 2024. Director Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO) On May 29, 2024, Thomas Kirk, Director at Myomo Inc (MYO), purchased 50,000 shares of the company, as reported in the SEC Filing. Insider Sale: Chief Medical Officer Harry Kovelman Sells 35,426 Shares of Myomo Inc (MYO) On May 15, 2024, Harry Kovelman, Chief Medical Officer of Myomo Inc (MYO), executed a sale of 35,426 shares of the company. Performance Overview Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return MYO S&P 500 YTD -0.16% +0.51% 1-Year +50.37% +24.11% 3-Year -27.73% +27.33%